The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
Year: 2016
Type: article
Abstract: The HCT-CI has been validated as a prognostic tool in several allo-HCT settings. However, it has not been studied in CD34-selected allo-HCT, an approach shown to significantly reduce GVHD and which is now under investigation in a phase 3 national study (BMT CTN 1301, NCT02345850).
Authors: Pere Barba, Ravin Ratan, Izaskun Ceberio, Patrick Hilden, Molly Maloy, Juliet N. Barker, Hugo Castro-Malaspina, Ann A. Jakubowski, Guenther Koehne, Esperanza Papadopoulos, Doris M. Ponce, Craig S. Sauter, Marcel R.M. van den Brink, James W. Young, Scott Avecilla, Richard Meagher, Sean M. Devlin, Richard J. O'Reilly, Sergio A. Giralt, Miguel-Angel Perales
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W4240210205